ES519254A0 - Procedimiento para la preparacion de nuevos compuestos de aroilimidazol-2-ona. - Google Patents

Procedimiento para la preparacion de nuevos compuestos de aroilimidazol-2-ona.

Info

Publication number
ES519254A0
ES519254A0 ES519254A ES519254A ES519254A0 ES 519254 A0 ES519254 A0 ES 519254A0 ES 519254 A ES519254 A ES 519254A ES 519254 A ES519254 A ES 519254A ES 519254 A0 ES519254 A0 ES 519254A0
Authority
ES
Spain
Prior art keywords
aroilimidazole
procedure
preparation
new
ona
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES519254A
Other languages
English (en)
Other versions
ES8402827A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Publication of ES8402827A1 publication Critical patent/ES8402827A1/es
Publication of ES519254A0 publication Critical patent/ES519254A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/70One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Luminescent Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
ES519254A 1981-03-05 1983-01-25 Procedimiento para la preparacion de nuevos compuestos de aroilimidazol-2-ona. Granted ES519254A0 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24088981A 1981-03-05 1981-03-05
US06/314,312 US4405628A (en) 1981-03-05 1981-10-23 4-Pyridylimidazolones and method of use

Publications (2)

Publication Number Publication Date
ES8402827A1 ES8402827A1 (es) 1984-03-01
ES519254A0 true ES519254A0 (es) 1984-03-01

Family

ID=26933806

Family Applications (2)

Application Number Title Priority Date Filing Date
ES510087A Expired ES8305352A1 (es) 1981-03-05 1982-03-03 Procedimiento para la preparacion de nuevos compuestos de aorilimidazol-2-ona.
ES519254A Granted ES519254A0 (es) 1981-03-05 1983-01-25 Procedimiento para la preparacion de nuevos compuestos de aroilimidazol-2-ona.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES510087A Expired ES8305352A1 (es) 1981-03-05 1982-03-03 Procedimiento para la preparacion de nuevos compuestos de aorilimidazol-2-ona.

Country Status (18)

Country Link
US (1) US4405628A (es)
EP (1) EP0059948B1 (es)
KR (1) KR890000765B1 (es)
AT (1) ATE16489T1 (es)
AU (1) AU557590B2 (es)
CA (1) CA1190550A (es)
DE (1) DE3267352D1 (es)
DK (1) DK168627B1 (es)
ES (2) ES8305352A1 (es)
GB (1) GB2096600B (es)
GR (1) GR76518B (es)
HK (1) HK61686A (es)
IE (1) IE52387B1 (es)
IL (1) IL65137A (es)
MY (1) MY8600700A (es)
NO (1) NO157175C (es)
NZ (1) NZ199885A (es)
PH (1) PH18345A (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367236A (en) * 1981-11-04 1983-01-04 Merrell Dow Pharmaceuticals Inc. Method for the treatment of cardiac failure with alkanoylimidazol-2-one derivatives
US4552880A (en) * 1983-02-15 1985-11-12 Merrell Dow Pharmaceuticals Inc. Aroylimidazolones
US4532250A (en) * 1983-11-23 1985-07-30 American Hospital Supply Corporation 5-Heteroarylimidazol-2-ones having cardiotonic activity
US4556665A (en) * 1984-07-09 1985-12-03 Schering A.G. Cardiotonic 1,3-dihydro-4-[[(imidazol-1-yl)aryl]carbonyl]imidazol-2-ones
ZA855592B (en) * 1984-07-30 1986-03-26 Merrell Dow Pharma The preparation of 1,3-dihydro-4-pyridoyl-2h-imidazol-2-ones
US4803278A (en) * 1984-07-30 1989-02-07 Merrell Dow Pharmaceuticals, Inc. Preparation of 1,3-dihydro-4-pyridoyl-2H-imidazol-2-ones
US4999365A (en) * 1987-03-20 1991-03-12 Merrell Dow Pharmaceuticals Inc. Method of reducing reperfusion injury with imidazol-2-thiones
ZA881807B (en) * 1987-03-20 1988-09-05 Merrell Dow Pharmaceuticals Inc. Method for reducing reperfusion injury with imidazol-2-thiones
ZA887662B (en) * 1987-10-19 1989-06-28 Merrell Dow Pharma Method for reducing reperfusion injury with imidazol-2-thione-carboxamides
WO1992000282A1 (en) * 1990-06-29 1992-01-09 The Upjohn Company Substituted 1-(alkoxyphenyl)piperazines with cns and antihypertensive activity
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
AU2008261102B2 (en) 2007-06-04 2013-11-28 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2522968T3 (es) 2008-06-04 2014-11-19 Synergy Pharmaceuticals Inc. Agonistas de guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
CA2730603C (en) 2008-07-16 2019-09-24 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
EP3366698A1 (en) 2011-03-01 2018-08-29 Synergy Pharmaceuticals Inc. Guanylate cyclase c agonists
JP6499591B2 (ja) 2013-02-25 2019-04-10 シナジー ファーマシューティカルズ インコーポレイテッド 結腸洗浄において用いるためのグアニル酸シクラーゼ受容体アゴニスト
AU2014235209B2 (en) 2013-03-15 2018-06-14 Bausch Health Ireland Limited Guanylate cyclase receptor agonists combined with other drugs
WO2014151206A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
EP4424697A2 (en) 2013-06-05 2024-09-04 Bausch Health Ireland Limited Ultra-pure agonists of guanylate cyclase c, method of making and using same
EP3492106B1 (en) 2013-08-09 2021-02-17 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
CN114340631A (zh) 2019-05-21 2022-04-12 阿德利克斯股份有限公司 用于降低患者的血清磷酸盐的组合

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2441933A (en) * 1945-07-30 1948-05-18 Hoffmann La Roche Substituted imidazolones and process of making them
US3538104A (en) * 1969-02-28 1970-11-03 Geigy Chem Corp Pyridyl-2-imidazolones
ZA803332B (en) * 1979-06-18 1981-01-28 Richardson Merrell Inc Novel 4-aroylimidazol-2-ones
NZ193935A (en) * 1979-06-18 1985-05-31 Richardson Merrell Inc 4-aroyl-imidazol-2-one derivatives;pharmaceutical compositions
PH18106A (en) * 1981-02-18 1985-03-21 Merrell Dow Pharma Novel-4-aroylimidazol-2-ones

Also Published As

Publication number Publication date
IE820491L (en) 1982-09-05
DK168627B1 (da) 1994-05-09
EP0059948B1 (en) 1985-11-13
DE3267352D1 (en) 1985-12-19
IE52387B1 (en) 1987-10-14
IL65137A0 (en) 1982-05-31
GR76518B (es) 1984-08-10
NO157175B (no) 1987-10-26
CA1190550A (en) 1985-07-16
DK95482A (da) 1982-09-06
KR830009046A (ko) 1983-12-17
US4405628A (en) 1983-09-20
NO157175C (no) 1988-02-03
NO820686L (no) 1982-09-06
GB2096600B (en) 1985-06-05
AU557590B2 (en) 1986-12-24
GB2096600A (en) 1982-10-20
EP0059948A1 (en) 1982-09-15
ES510087A0 (es) 1983-04-16
ES8305352A1 (es) 1983-04-16
HK61686A (en) 1986-08-29
MY8600700A (en) 1986-12-31
KR890000765B1 (ko) 1989-04-05
NZ199885A (en) 1985-04-30
ATE16489T1 (de) 1985-11-15
AU8103782A (en) 1982-09-09
PH18345A (en) 1985-06-05
ES8402827A1 (es) 1984-03-01
IL65137A (en) 1987-02-27

Similar Documents

Publication Publication Date Title
ES510087A0 (es) Procedimiento para la preparacion de nuevos compuestos de aorilimidazol-2-ona.
ES504955A0 (es) Procedimiento para la preparacion de derivados de aminoacidos
ES518133A0 (es) Procedimiento para la preparacion de derivados de aminoacidos.
ES520988A0 (es) Procedimiento para la preparacion de nuevos 6,11-dihidro-dibenzo-(b,e)-tiepin-11-n-alcohilnorescopin-eteres.
DK505983D0 (da) Imidazolylalkylthienyl-tetrahydropyridaziner og fremgangsmade til fremstilling deraf
PT77898B (en) Process for the preparation of substituted 4-amino-methylenochromanes and 4-aminomethylenecromenes acting on the blood circulation and application thereof in the preparation of pharmaceutical compositions acting on the blood circulation
ES532032A0 (es) Procedimiento para la preparacion de nuevos derivados de acidos biliares
ES549776A0 (es) Procedimiento para la preparacion de pirrolo-bencimidazoles
ES507810A0 (es) Procedimiento para hidroformilar compuestos olefinicamente insaturados.
ES507284A0 (es) Procedimiento para la preparacion de derivados de aminoaci- dos.
MX162869B (es) Procedimiento para la preparacion de complejos de anfotero-acido graso
ES495826A0 (es) Procedimiento para la obtencion de acido fosfonohidroxiace- tico
ES499363A0 (es) Procedimiento para la obtencion de derivados de fenilpipera-cina de 1,3,4-oxadiazolilfenoles
ES492143A0 (es) Procedimiento para la obtencion de derivados de 3,4,5-trihi-droxipiperidina
DK320081A (da) Fremgangsmaade til fremstilling af thiazolyl-2-oxamidsyrederivater
ES523457A0 (es) Procedimiento para la preparacion discontinua de vinagre
ES494594A0 (es) Procedimiento para la preparacion de derivados de acidos al-canocarboxilicos
ES490959A0 (es) Procedimiento para la preparacion de derivados de acidos pi-rrolidinilsulfamoilbenzoicos sustituidos
ES2044853T3 (es) Derivados de 1,4-di-hidro-piridina, procedimiento para su fabricacion y medicamentos que contienen estos compuestos.
IT8324141A0 (it) Preparato per la cura delle ustioni.
ES494417A0 (es) Procedimiento para la preparacion de 2-(2-cloro-4-ciclopro- pil-fenil-imino)-imidazolidina
ES530605A0 (es) Procedimiento para fabricar compuestos piperidinonicos eficaces en el tratamiento de cardiopatias
ES513847A0 (es) "procedimiento para la preparacion de nuevos derivados de acidos 2-amino-carboxilicos".